Impact of <scp>direct‐acting</scp> antiviral treatment for hepatitis C on cardiovascular diseases and extrahepatic cancers

Abstract

DAAs were not associated with extrahepatic cancer development or reduction. They were associated with a decreased risk of PAD and an increased risk of ACD, supporting long-term cardiac monitoring after DAA therapy.